Agendia has tapped Al Luderer to serve on its supervisory board. Luderer is CEO of BioTrove, and he is on the scientific advisory board at Washington University's Department of Biomedical Engineering. He formerly was CEO of Light Sciences Corporation, and he has been chief operating officer at BioMerieux. He also previously served as vice president of technology development and support at Boehringer Mannheim.
Enzo Biochem has appointed Kevin Krenitsky as president of its Enzo Clinical Labs subsidiary.